KR890700030A - 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 - Google Patents

인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법

Info

Publication number
KR890700030A
KR890700030A KR1019880701053A KR880701053A KR890700030A KR 890700030 A KR890700030 A KR 890700030A KR 1019880701053 A KR1019880701053 A KR 1019880701053A KR 880701053 A KR880701053 A KR 880701053A KR 890700030 A KR890700030 A KR 890700030A
Authority
KR
South Korea
Prior art keywords
proteins
peptides
viruses
pbomp
influenzae
Prior art date
Application number
KR1019880701053A
Other languages
English (en)
Other versions
KR960016208B1 (ko
Inventor
로버트 에이. 데이치
그레이 즈로트닉
블루스 그리언
Original Assignee
프락시스 바이오로직스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프락시스 바이오로직스, 인코포레이티드 filed Critical 프락시스 바이오로직스, 인코포레이티드
Publication of KR890700030A publication Critical patent/KR890700030A/ko
Application granted granted Critical
Publication of KR960016208B1 publication Critical patent/KR960016208B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
KR1019880701053A 1986-12-31 1987-12-23 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법. KR960016208B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US94836486A 1986-12-31 1986-12-31
US948,364 1986-12-31
US2084987A 1987-03-02 1987-03-02
US020,849 1987-03-02
US13207387A 1987-12-11 1987-12-11
US132,073 1987-12-11
PCT/US1987/003423 WO1988004932A1 (en) 1986-12-31 1987-12-23 Vaccines and diagnostic assays for haemophilus influenzae

Publications (2)

Publication Number Publication Date
KR890700030A true KR890700030A (ko) 1989-03-02
KR960016208B1 KR960016208B1 (ko) 1996-12-06

Family

ID=27361526

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880701053A KR960016208B1 (ko) 1986-12-31 1987-12-23 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법.

Country Status (9)

Country Link
EP (2) EP0786472A1 (ko)
JP (5) JP2534529B2 (ko)
KR (1) KR960016208B1 (ko)
AT (1) ATE159170T1 (ko)
AU (1) AU615429B2 (ko)
CA (1) CA1335655C (ko)
DE (1) DE3752131T2 (ko)
DK (1) DK482788A (ko)
WO (1) WO1988004932A1 (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
NZ219515A (en) * 1987-02-10 1989-09-27 Wellcome Found Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
AU623353B2 (en) * 1987-12-10 1992-05-14 Board Of Regents, The University Of Texas System Methods and compositions for the production of haemophilus influenzae type b major outer membrane protein antigens
CA1340888C (en) * 1988-09-01 2000-02-01 Algis Anilionis Vaccines and diagnostic assays for haemophilus influenzae
EP0606921B1 (en) * 1989-03-09 2000-08-02 American Cyanamid Company Method of isolating haemophilus influenzae protein E
ATE132160T1 (de) * 1989-03-29 1996-01-15 Univ New York State Res Found Verfahren zur reinigung von aussenmembran-protein von haemophilus influenza
FI903414A (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.
DE69127628T2 (de) * 1991-10-01 1998-01-22 Biostar Inc Hochempfindlicher optischer Immunoassay durch Gebrauch von Enzymmarkierten Reagenz
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
DE4232073C2 (de) * 1992-09-25 2001-09-20 Chiron Behring Gmbh & Co Verfahren zur immunchemischen Quantifizierung von inaktivierten, immunreaktiven Antigenen
JPH07245887A (ja) * 1994-03-08 1995-09-19 Rhythm Watch Co Ltd バックアップバッテリー回路
KR20040090987A (ko) * 2002-01-25 2004-10-27 에리코 인터내셔날 코포레이션 용접 장치 및 용접 방법
AU2004215133B2 (en) 2003-02-27 2010-10-14 Yeda Research And Development Co. Ltd. Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
JP5396498B2 (ja) 2012-03-02 2014-01-22 株式会社エス・ケー・ジー 発光装置
CN105242040B (zh) * 2014-08-18 2017-01-18 董俊 人流感嗜血杆菌量子点免疫层析检测卡及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US304863A (en) 1884-09-09 Railway car
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4261968A (en) * 1979-05-10 1981-04-14 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
FI63596C (fi) * 1981-10-16 1983-07-11 Orion Yhtymae Oy Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
US4455296A (en) * 1982-02-02 1984-06-19 Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
GB8426469D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
US5173294A (en) * 1986-11-18 1992-12-22 Research Foundation Of State University Of New York Dna probe for the identification of haemophilus influenzae

Also Published As

Publication number Publication date
JPH11146797A (ja) 1999-06-02
EP0294469A4 (en) 1990-02-05
DE3752131D1 (de) 1997-11-20
AU615429B2 (en) 1991-10-03
JP3124753B2 (ja) 2001-01-15
AU1154188A (en) 1988-07-27
JP2872254B2 (ja) 1999-03-17
JPH1057059A (ja) 1998-03-03
DK482788A (da) 1988-10-31
JP3023089B2 (ja) 2000-03-21
DK482788D0 (da) 1988-08-30
KR960016208B1 (ko) 1996-12-06
JPH11253160A (ja) 1999-09-21
EP0294469B1 (en) 1997-10-15
JPH01502190A (ja) 1989-08-03
DE3752131T2 (de) 1998-02-26
EP0294469A1 (en) 1988-12-14
JPS63502314A (ja) 1988-09-01
JP2534529B2 (ja) 1996-09-18
ATE159170T1 (de) 1997-11-15
JP3066339B2 (ja) 2000-07-17
WO1988004932A1 (en) 1988-07-14
CA1335655C (en) 1995-05-23
EP0786472A1 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
SE8701413D0 (sv) Expression and purification of an htlv-iii gag/env gene protein
RU94042722A (ru) Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина
ZA891067B (en) Pox virus vectors
DK672789D0 (da) Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme
US4140763A (en) Vaccine for foot and mouth disease
KR900701291A (ko) 혈호균속 인플루엔자용 백신과 진단검사법
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
EP0538341B1 (en) Ehv-4 glycoprotein vaccine
NO902251D0 (no) Fremstilling av gonorrheiske p1-proteiner og vaksiner.
FI885296A (fi) Rekombinant hiv-2 polypeptid.
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
DE69332264D1 (de) Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe
NZ242707A (en) Nucleotide sequence and polypeptide of mareks disease virus and vaccine containing the polypeptide
ATE274059T1 (de) Transferrinrezeptorgene
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов
Fodor Live recombinant vaccines for humans
ATE143373T1 (de) Proteine, vakzine und nucleinsäuren
Splitter et al. How DNA studies may advance knowledge of pathogenesis and immunity

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20101129

Year of fee payment: 15

EXPY Expiration of term